ATAI Life Sciences AG acquires Kures, Inc.

On July 9, 2020, ATAI Life Sciences AG acquired Kures, Inc., a life science company in New York, United States.

Deal at a glance

AnnouncedJuly 9, 2020 TypeAdd-on Acquistion TargetKures, Inc. Buyer ATAI Life Sciences AG SectorLife Science LocationNew York, United States ValueNot disclosed

Target company

Kures, Inc.

New York, United States

Life Sciencesector

1997founded

Activestatus

View the company profile →

Buyer

ATAI Life Sciences AG

Company · 3 deals on record

1st transaction in life science
1st transaction in United States

3deals, all time

3in this sector

2021latest

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026

ArtesRx LLCSame sector and country · Aug 2026

Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Kures, Inc.?ATAI Life Sciences AG acquired Kures, Inc. on July 9, 2020.

What type of deal was it?It was a add-on acquistion in the life science sector in 2020.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).